Updated: Apr 16, 2026

Perturbing Endothelial Biomechanics via Connexin 43 Structural Disruption
Published on: October 4, 2019
1Primus Pharmaceuticals, Inc., Clinical Development, Scottsdale, Arizona, USA.
No abstract available in PubMed .
You might also read
Articles linked to this work by shared authors, journal, and citation graph.